NCT06081582 2023-10-13
Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
Clinical Trials
6 trialsNCT05803915 2023-04-07
Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02915432 2021-12-13
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT04947241 2021-07-01
Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 1 Unknown
NCT04523883 2021-04-15
IMPORT
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT04164238 2019-11-15
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown